Dr. E. Prashanthi Reddy
MBBS · DGO · Diploma in ART — Kiel University, Germany
Founder & Medical Director — Mother Hospitals & IVF Center, Boduppal
TGMC Registration: 50624 · 19+ Years of Clinical Experience · 5000+ IVF Cycles
Perimenopause, menopause, post-menopause — hot flashes, sleep issues, mood changes, bone health, HRT and non-hormonal options. Compassionate evidence-based care. Dr. E. Prashanthi Reddy, Boduppal.
Menopause is a natural life transition — not a disease. But the symptoms and long-term health changes require expert management and individual assessment.
If your periods stop before age 40, this is not natural menopause — it is Premature Ovarian Insufficiency (POI). POI requires urgent specialist evaluation, as it has different implications for bone health, cardiovascular health, fertility, and long-term wellbeing. FSH will be elevated on blood testing. HRT is strongly recommended until at least the average age of natural menopause.
Dr. Prashanthi has specific expertise in managing POI — including fertility preservation and HRT optimisation. Do not accept a dismissive "early menopause" label without a full investigation.
Symptoms vary widely between women — from barely noticeable to severely disruptive. You do not have to simply put up with them.
Vasomotor symptoms — sudden intense heat, flushing, and sweating — affect 70–80% of menopausal women. They can occur many times a day and night, severely disrupting sleep and daily function. The most effectively treated symptom with HRT.
Insomnia, frequent night waking (often triggered by night sweats), and difficulty returning to sleep are extremely common during perimenopause and menopause. Poor sleep worsens mood, cognitive function, and cardiovascular risk. Treating the underlying hormonal cause is more effective than sleeping tablets alone.
Anxiety, low mood, irritability, and tearfulness are common — partly hormonal (falling oestrogen directly affects serotonin and dopamine pathways) and partly driven by sleep deprivation and life stressors. These symptoms are real and treatable — they are not 'just getting older'.
Genitourinary syndrome of menopause (GSM) — vaginal dryness, thinning, reduced lubrication, altered pH — causes painful intercourse, recurrent urinary infections, and urinary urgency. Affects 50–70% of postmenopausal women but is significantly undertreated. Highly responsive to local vaginal oestrogen.
Difficulty concentrating, word-finding difficulties, and memory lapses ('menopausal brain fog') are common and understandably frightening. They are caused by hormonal fluctuations affecting neurological function — not early dementia. These symptoms typically improve with HRT and sleep restoration.
Oestrogen is essential for maintaining bone density. After menopause, bone density declines rapidly — particularly in the first 5 years. This silent process leads to osteoporosis and fracture risk. Prevention and early treatment are far more effective than treating established osteoporosis.
Beyond symptoms, the hormonal changes of menopause have significant long-term implications for bone, heart, and brain health.
Oestrogen protects bone density. After menopause, women lose approximately 2–3% of bone density per year in the early postmenopausal period. This leads to osteoporosis — thinning and weakening of bone — and dramatically increases the risk of vertebral (spine), hip, and wrist fractures. A hip fracture in an older woman carries a 20–30% mortality risk within one year.
Dr. Prashanthi recommends a DEXA scan at menopause (or sooner with risk factors), calcium 1200mg/day, vitamin D 1000–2000 IU/day, weight-bearing exercise, and HRT or bisphosphonates if indicated.
Oestrogen is cardioprotective — it maintains healthy cholesterol levels, arterial flexibility, and blood pressure regulation. Before menopause, women have a lower risk of cardiovascular disease than men of the same age. After menopause, the risk rises rapidly to match men's. Women with premature menopause (POI) have a significantly elevated cardiovascular risk that requires active management.
HRT started within 10 years of menopause (the 'window of opportunity') has been shown to reduce cardiovascular risk. This is one of the most important and underappreciated benefits of early HRT initiation.
HRT remains the most effective treatment for menopausal symptoms. The evidence base has evolved significantly — modern HRT is far safer than older formulations suggested.
The risks of modern HRT are small and depend on type, route, and duration:
HRT is not a one-size-fits-all prescription. Dr. Prashanthi takes a detailed personal and family history, assesses cardiovascular and cancer risk, discusses individual symptom burden and priorities, and selects the most appropriate HRT formulation. Transdermal oestrogen (gel or patch) with body-identical micronised progesterone is the preferred approach for most women — offering the best efficacy with the most favourable safety profile.
HRT is not a permanent commitment — most women try it, assess whether it helps, and review annually. Stopping HRT gradually (rather than abruptly) avoids a rapid return of symptoms.
For women who cannot or choose not to take systemic HRT, effective alternatives are available.
Vaginal oestrogen (pessaries, cream, or ring) treats genitourinary syndrome of menopause (GSM) — vaginal dryness, discomfort, and recurrent urinary infections. It is absorbed minimally into the bloodstream and does not significantly raise systemic oestrogen levels. It is considered safe even for women in whom systemic HRT is contraindicated, including most breast cancer survivors. There is no good evidence that local vaginal oestrogen increases breast cancer risk.
MBBS · DGO · Diploma in ART — Kiel University, Germany
Founder & Medical Director — Mother Hospitals & IVF Center, Boduppal
TGMC Registration: 50624 · 19+ Years of Clinical Experience · 5000+ IVF Cycles
Common questions about perimenopause, menopause, HRT, and long-term women's health.
Perimenopause is the transitional phase leading up to menopause, typically lasting 4–10 years. During perimenopause, oestrogen and progesterone levels fluctuate unpredictably, periods become irregular, and menopausal symptoms begin. Menopause is diagnosed retrospectively after 12 consecutive months without a menstrual period. The average age of menopause in Indian women is 46–51 years. Post-menopause refers to life after menopause — when oestrogen levels remain consistently low.
Modern HRT is safe for the majority of healthy women under 60 who are within 10 years of their last period. The benefits — relief of vasomotor symptoms, bone protection, cardiovascular protection when started early, improved mood and sleep — generally outweigh the small risks for most women. The risks (small increase in breast cancer risk with combined HRT, VTE risk with oral oestrogen) can be minimised by using transdermal (patch or gel) oestrogen and body-identical micronised progesterone. Dr. Prashanthi conducts a full individual risk assessment before prescribing HRT and reviews it annually.
Many women gain weight around the time of menopause. The hormonal shift causes a redistribution of fat from the hips and thighs to the abdomen (central adiposity), which increases cardiovascular risk independent of total body weight. Metabolism also slows slightly. Regular exercise (both aerobic and resistance training), dietary changes (reducing refined carbohydrates and alcohol), and in some cases HRT (which reduces abdominal fat redistribution) can help manage menopausal weight gain. Weight gain at menopause is not inevitable — it is manageable with the right support.
Yes. Although fertility declines significantly during perimenopause, ovulation still occurs occasionally and pregnancy is possible until menopause is confirmed (12 months without a period). Contraception is recommended until one full year after the last period. If you are in perimenopause and wish to conceive, Dr. Prashanthi can discuss the options available — AMH testing, ovarian reserve assessment, and if needed, IVF. Conception in perimenopause carries increased risk of chromosomal abnormalities and pregnancy complications, which Dr. Prashanthi will discuss at consultation.
Vaginal dryness (genitourinary syndrome of menopause or GSM) is caused by falling oestrogen levels, which thin the vaginal walls, reduce natural lubrication, and alter vaginal pH. It causes discomfort during intercourse, recurrent urinary infections, urinary urgency, and irritation. Local vaginal oestrogen (pessaries, cream, or ring) is the most effective treatment and is extremely safe — it is absorbed minimally and does not significantly increase systemic oestrogen. Non-hormonal moisturisers and lubricants also help. This condition is underdiagnosed and undertreated — please do not suffer in silence.
There is no fixed duration. Most women take HRT for 2–5 years to manage symptoms during the menopausal transition, then gradually taper off. Some women choose to continue longer for ongoing bone protection or quality of life — particularly those with POI (premature ovarian insufficiency), who should continue until at least age 51. The decision is reviewed annually with Dr. Prashanthi based on symptoms, risk factors, and individual preference. Stopping HRT abruptly can cause symptoms to return — a gradual taper over several weeks is recommended.
A DEXA (dual-energy X-ray absorptiometry) scan measures bone mineral density and diagnoses osteoporosis or osteopenia. It is recommended for all women by age 65, or earlier (at menopause or soon after) if there are risk factors such as early menopause (POI), family history of osteoporosis or hip fracture, low body weight, long-term steroid use, or previous fragility fractures. Blood tests for vitamin D, calcium, and thyroid function are also routinely checked. Dr. Prashanthi will refer for DEXA and advise on supplements, lifestyle, and medication (bisphosphonates if needed) based on the result.
If periods stop before age 40, this is called Premature Ovarian Insufficiency (POI) — not natural menopause. POI requires specialist evaluation. FSH levels will be elevated (typically above 25 IU/L on two tests 4–6 weeks apart). POI carries specific risks including accelerated bone loss, cardiovascular risk, and significant psychological impact. HRT is strongly recommended until at least the average age of natural menopause (approximately 51) to protect bone and cardiovascular health — this is not optional for most women with POI. Fertility options, including IVF with donor eggs, should be discussed without delay. Dr. Prashanthi has expertise in managing POI compassionately and comprehensively.
Explore other specialist services at Mother Hospitals & IVF Center.
You do not have to manage menopause alone or in silence. Dr. E. Prashanthi Reddy provides evidence-based, individualised menopause care — from HRT assessment to bone health, mood support, and long-term wellbeing planning.
Dr. E. Prashanthi Reddy · TGMC Reg: 50624